Potential coronavirus drugs, illustration
Numéro d’image : 13196089
| Illustration of molecules of the protease inhibitor camostat mesilate (right), molecules of the nucleotide analogue remdesivir (left) and a SARS-CoV-2 coronavirus particle (centre). Camostat and remdesivir are being investigated as treatments for covid-19, the respiratory infection caused by the Sars-CoV-2 (previously 2019-nCoV) virus. Camostat blocks the virus from entering human cells. Remdesivir disrupts the production of RNA (ribonucleic acid), the coronavirus genome and so stops the virus from replicating. Sars-CoV-2 was first identified in Wuhan, China, in December 2019. As of March 2020, the virus has spread to many countries worldwide and has been declared a pandemic. Over 100, 000 have been infected with several thousand deaths. | |
| Licence : | Libre de droits |
| Crédit: | Science Photo Library / Gaertner, Juan |
| Model Release : | Non requis |
| Property Release : | Non requis |
| Restrictions : | - |
Prix pour cette image À partir de 29 €
Pour une utilisation numérique (72 dpi)
À partir de 29 €
Pour un usage d'impression (300 dpi)
À partir de 325 €
Mots clés
- 2019,
- 2019 ncovid,
- 2019-ncovid,
- antiviral,
- aucun,
- biochimie,
- biochimique,
- biologie,
- biologique,
- Chine,
- corona virus,
- coronavirus,
- coronavirus Novel,
- covid 19,
- covid-19,
- covid19,
- drogue,
- épidémie,
- épidémique,
- expérimental,
- expérimentale,
- fatal,
- fatale,
- formules chimique,
- hcov,
- illustration,
- infectieux,
- inhibiteur de protéase,
- IP,
- médecine,
- médical,
- médicale,
- micro-organisme,
- microbe,
- microbiologie,
- microbiologique,
- modèle moléculaire,
- molécule,
- mortel,
- mortelle,
- mortellement,
- nouveau,
- oeuvre,
- pandémie,
- pandémique,
- particule,
- pathogène,
- personne,
- pharmaceutique,
- pharmacologie,
- pharmacologique,
- pneumonia,
- pneumonie,
- prodrogue,
- respiratoire,
- SARS Cov 2,
- structure moléculaire,
- traitement,
- viral,
- virion,
- virologie,
- virus,
- virus d'ARN